Effect of Altered Iron Metabolism on Hyperinflammation and Coagulopathy in Patients with Critical COVID-19: A Retrospective Study
View/ Open
Access
info:eu-repo/semantics/openAccessDate
15.01.2022Author
Kıran,Tuğba RaikaOtlu, Önder
Erdem, Mehmet
Korkmaz, Kübranur
Ota Günay, Özge
İn, Erdal
Bay Karabulut, Aysun
Metadata
Show full item recordCitation
Önder Otlu, Mehmet Erdem, Kübranur Korkmaz, Özge Ota Gunay, Erdal İn, Tuğba Raika Kıran, Aysun Bay Karabulut. Effect of AlteredIronMetabolism on HyperinflammationandCoagulopathy in Patientswith Critical COVID-19: A RetrospectiveStudy. Int J AcadMedPharm, 2022; 4 (1): 60-64.Abstract
Abstract: A novel coronavirus disease 2019 (COVID-19) outbreak has started in Wuhan, China, caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The relationship between altered iron homeostasis and
hyperinflammation may be hallmarks of COVID-19 disease. We aimed to compare some iron (ferritin and iron),
inflammation (C-reactive protein [CRP], hemoglobin, lactate dehydrogenase [LDH], neutrophil) and coagulation
(prothrombin time [PT], activated partial thromboplastin time [APTT], D-dimer, platelet) marker results of critical
COVID-19 patients with healthy controls results. In this single center retrospective study, 50 critical patients
diagnosed with COVID-19 were included, demographic, clinical characteristics, severity of disease and laboratory
test results were elicited from electronic medical records and compared to 50 healthy people. A statistically
significant increase in CRP, LDH, neutrophil, PT, APTT, D-dimer ferritin levels was observed in critical
COVID-19 patients compared with healthy people while a statistically significant decrease was observed in
hemoglobin and iron levels. In addition, no statistically significant change in platelet levels was observed.
Ferroptosis may be a significant cause of multiple organ failure in critical COVID-19 patients. Ferroptosis inhibitors
might have potential to combat ferroptosis in COVID-19. Therefore, larger studies are needed to ferroptosis in
COVID-19 in vivo and in vitro.